These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New York
|
11-3474831
|
|
(State
or other jurisdiction of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
|
Large
accelerated filer
|
¨
|
Accelerated
filer
|
¨
|
|
Non-accelerated
filer
|
¨
(Do not check if a smaller
reporting company)
|
Smaller
reporting company
|
x
|
|
Page
Number
|
||||
|
Part
I
|
FINANCIAL
INFORMATION
|
|||
|
Item
1.
|
Consolidated
Financial Statements
|
|||
|
Consolidated
Balance Sheets as of September 30, 2010 and December 31,
2009
|
2
|
|||
|
Consolidated
Statements of Operations for the Three and Nine Month Periods Ended
September 30, 2010 and 2009
|
3
|
|||
|
Consolidated Statements of Cash Flows for the Nine
Month Periods Ended September 30, 2010 and 2009
|
4
|
|||
|
Notes
to Consolidated Financial Statements
|
5
|
|||
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
10
|
||
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
14
|
||
|
Item
4.
|
Controls
and Procedures
|
14
|
||
|
Part
II
|
OTHER INFORMATION
|
|||
|
Item
6.
|
Exhibits
|
14
|
||
|
SIGNATURES
|
15
|
|||
|
EXHIBITS
|
E-1
|
|
|
September 30, 2010
|
December 31, 2009
|
||||||
|
(Unaudited)
|
(Audited)
|
|||||||
| Assets | ||||||||
|
Current
assets:
|
||||||||
|
Cash
and cash equivalents
|
$ | 959,918 | $ | 707,449 | ||||
|
Investment
in marketable securities
|
— | 404,268 | ||||||
|
Total cash and cash equivalents and investment in
marketable securities
at
fair value
|
959,918 | 1,111,717 | ||||||
|
Short
term loans
|
7,066,200 | 6,476,621 | ||||||
|
Interest
receivable on short term loans
|
69,314 | 60,207 | ||||||
|
Other
current assets
|
73,328 | 26,568 | ||||||
|
Total
current assets
|
8,168,760 | 7,675,113 | ||||||
|
Property
and equipment, net
|
3,184 | 5,458 | ||||||
|
Security
deposit
|
17,515 | 17,515 | ||||||
|
Investment
in privately held company, at cost
|
100,000 | 100,000 | ||||||
|
Total
assets
|
$ | 8,289,459 | $ | 7,798,086 | ||||
|
Liabilities
and Shareholders’ Equity
|
||||||||
|
Current
liabilities:
|
||||||||
|
Lines
of credit
|
$ | 300,000 | $ | — | ||||
|
Accounts
payable and accrued expenses
|
32,310 | 77,768 | ||||||
|
Deferred
origination fees
|
40,626 | 102,751 | ||||||
|
Income
taxes payable
|
145,513 | 162,182 | ||||||
|
Total
current liabilities
|
518,449 | 342,701 | ||||||
|
Commitments and
contingencies
|
||||||||
| Shareholders’ equity: | ||||||||
|
Preferred
shares - $.01 par value; 5,000,000 shares authorized; no shares
issued
|
— | — | ||||||
|
Common
shares - $.001 par value; 25,000,000 authorized;
3,405,190
issued and
3,324,459
outstanding
|
3,405 | 3,405 | ||||||
|
Additional
paid-in capital
|
9,563,823 | 9,476,762 | ||||||
|
Treasury
stock, at cost- 80,731 shares
|
(241,400 | ) | (241,400 | ) | ||||
|
Accumulated
other comprehensive income
|
— | 123,823 | ||||||
|
Accumulated
deficit
|
(1,554,818 | ) | (1,907,205 | ) | ||||
|
Total
shareholders’ equity
|
7,771,010 | 7,455,385 | ||||||
|
Total
liabilities and shareholders’ equity
|
$ | 8,289,459 | $ | 7,798,086 | ||||
|
Three Months
Ended
September 30
,
|
Nine Months
Ended
September 30
,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Interest
income from short term loans
|
$ | 255,869 | $ | 235,249 | $ | 751,733 | $ | 632,864 | ||||||||
|
Origination
fees
|
50,593 | 53,359 | 160,932 | 137,304 | ||||||||||||
|
Total
Revenue
|
306,462 | 288,608 | 912,665 | 770,168 | ||||||||||||
|
Operating
costs and expenses:
|
||||||||||||||||
|
Interest
expense on lines of credit used
|
6,900 | — | 21,627 | — | ||||||||||||
|
General
and administrative expenses
|
182,855 | 148,164 | 507,382 | 453,267 | ||||||||||||
|
Total
operating costs and expenses
|
189,755 | 148,164 | 529,009 | 453,267 | ||||||||||||
|
Income
from operations
|
116,707 | 140,444 | 383,656 | 316,901 | ||||||||||||
|
Interest
and dividend income
|
177 | 3,581 | 4,342 | 19,419 | ||||||||||||
|
Realized
loss on marketable securities
|
— | — | — | (5,940 | ) | |||||||||||
|
Realized
gain (loss) on marketable securities that were previously marked
down
|
— | (8,004 | ) | 151,419 | 10,654 | |||||||||||
|
Total
other income (expense)
|
177 | (4,423 | ) | 155,761 | 24,133 | |||||||||||
|
Income
from operations before
income
tax expense
|
116,884 | 136,021 | 539,417 | 341,034 | ||||||||||||
|
Income
tax expense
|
(60,030 | ) | (52,428 | ) | (187,030 | ) | (111,831 | ) | ||||||||
|
Net
Income
|
$ | 56,854 | $ | 83,593 | $ | 352,387 | $ | 229,203 | ||||||||
|
Basic
and diluted net income per common share outstanding:
|
||||||||||||||||
|
—Basic
|
$ | 0.02 | $ | 0.03 | $ | 0.11 | $ | 0.07 | ||||||||
|
—Diluted
|
$ | 0.02 | $ | 0.03 | $ | 0.10 | $ | 0.07 | ||||||||
|
Weighted
average number of common shares outstanding
|
||||||||||||||||
|
—Basic
|
3,324,459 | 3,325,760 | 3,324,459 | 3,325,760 | ||||||||||||
|
—Diluted
|
3,380,406 | 3,333,628 | 3,371,971 | 3,327,364 | ||||||||||||
|
Nine Months Ended September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash
flows from operating activities:
|
||||||||
|
Net
income
|
$ | 352,387 | $ | 229,203 | ||||
|
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
||||||||
|
Depreciation
and amortization
|
2,274 | 3,205 | ||||||
|
Non
cash compensation expense
|
59,099 | 61,280 | ||||||
|
Realized
loss on sale of marketable securities
|
— | 5,940 | ||||||
|
Realized
gain on marketable securities that were previously marked
down
|
(151,419 | ) | (10,654 | ) | ||||
|
Changes
in operating assets and liabilities:
|
||||||||
|
Interest
receivable on short term loans
|
(9,107 | ) | (39,523 | ) | ||||
|
Due
from purchaser
|
— | 23,881 | ||||||
|
Other
current and non current assets
|
(46,760 | ) | (19,630 | ) | ||||
|
Accounts
payable and accrued expenses
|
(17,496 | ) | (33,272 | ) | ||||
|
Deferred
origination fees
|
(62,125 | ) | 46,530 | |||||
|
Income
taxes payable
|
(16,669 | ) | 81,078 | |||||
|
Net
cash provided by operating activities
|
110,184 | 348,038 | ||||||
|
Cash
flows from investing activities:
|
||||||||
|
Proceeds
from sale of marketable securities, auction rate securities and annuity
contract
|
431,864 | 253,525 | ||||||
|
Issuance
of short term and long term loans
|
(3,912,500 | ) | (4,988,030 | ) | ||||
|
Collection
received from short term loans
|
3,322,921 | 3,585,463 | ||||||
|
Net
cash used in investing activities
|
(157,715 | ) | (1,149,042 | ) | ||||
|
Cash
flows from financing activities:
|
||||||||
|
Use
of line of credit
|
300,000 | 156,582 | ||||||
|
Net
cash provided by financing activities
|
300,000 | 156,582 | ||||||
|
Net
increase (decrease) in cash
|
252,469 | (644,422 | ) | |||||
|
Cash
and cash equivalents, beginning of the year
|
707,449 | 884,296 | ||||||
|
Cash
and cash equivalents, end of period
|
$ | 959,918 | $ | 239,874 | ||||
|
Supplemental
Cash Flow Information:
|
||||||||
|
Taxes
paid during the period
|
$ | 203,669 | $ | 30,753 | ||||
|
Interest
paid during the period
|
$ | 21,627 | $ | 746 | ||||
|
Non-cash
investing
and financing activities:
|
||||||||
|
Forgiveness
of debt
|
$ | 27,961 | $ | — | ||||
|
1.
|
THE
COMPANY
|
|
2.
|
RECENT
TECHNICAL ACCOUNTING PRONOUNCEMENTS
|
|
3.
|
SHORT
TERM COMMERCIAL LOANS
|
|
4.
|
EARNINGS
PER SHARE OF COMMON STOCK
|
|
Three Months
Ended September 30,
|
Nine Months
Ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Basic
|
3,324,459 | 3,325,760 | 3,324,459 | 3,325,760 | ||||||||||||
|
Incremental
shares for assumed conversion of options
|
55,947 | 7,868 | 47,512 | 1,604 | ||||||||||||
|
Diluted
|
3,380,406 | 3,333,628 | 3,371,971 | 3,327,364 | ||||||||||||
|
5.
|
STOCK
– BASED COMPENSATION
|
|
Shares
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Term (in
years)
|
Aggregate
Intrinsic
Value
|
|||||||||||||
|
Outstanding
at December 31, 2009
|
699,000 | $ | 1.87 | |||||||||||||
|
Granted
|
98,000 | 1.40 | ||||||||||||||
|
Exercised
|
— | — | ||||||||||||||
|
Forfeited
|
(91,000 | ) | 4.15 | |||||||||||||
|
Outstanding
at September 30, 2010
|
706,000 | $ | 1.51 | 2.22 | $ | 578,198 | ||||||||||
|
Vested
and exercisable at September 30, 2010
|
609,667 | $ | 1.58 | 1.95 | $ | 524,501 | ||||||||||
|
Item
3.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
|
|
|
(a)
|
Evaluation
and Disclosure Controls and
Procedures
|
|
|
(b)
|
Changes
in Internal Control Over Financial
Reporting
|
|
Item
6.
|
EXHIBITS
|
|
Exhibit No.
|
Description
|
|
|
31.1
|
Chief
Executive Officer Certification as required under section 302 of the
Sarbanes Oxley Act (filed herewith)
|
|
|
31.2
|
Chief
Financial Officer Certification as required under section 302 of the
Sarbanes Oxley Act (filed herewith)
|
|
|
32.1*
|
Chief
Executive Officer Certification pursuant to 18 U.S.C. section 1350 as
adopted pursuant to section 906 of the Sarbanes Oxley Act (furnished
herewith)
|
|
|
32.2*
|
|
Chief
Financial Officer Certification pursuant to 18 U.S.C. section 1350 as
adopted pursuant to section 906 of the Sarbanes Oxley Act (furnished
herewith)
|
|
Manhattan
Bridge Capital, Inc. (Registrant)
|
|
|
Date: October
27, 2010
|
By: /s/ Assaf
Ran
|
|
Assaf
Ran, President and Chief Executive Officer
|
|
|
(Principal
Executive Officer)
|
|
|
Date: October
27, 2010
|
By: /s/ Inbar
Evron-Yogev
|
|
Inbar
Evron-Yogev, Chief Financial Officer
|
|
|
(
Principal Financial and Accounting
Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|